Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Imagerie cérébrale (TEP IRM)

Major cross-functional project NeuroPrems

Last update: 06/07/2025 Reading time: 1min

Redefining neurodegenerative & neuroinflammatory disease boundaries and trajectories

The context

The NeuroPrems transversal program aims to address the following gap of knowledge: 

  • Are there common pathways underlying the pre-symptomatic phase of neuro-degenerative & neuro-inflammatory diseases? 
  • Can we identify modulators of disease conversion & progression to derive efficient therapies and prevent disease conversion and progression?

The primary objective of Neuroprems is to identify changes in multimodal markers of neurodegeneration and neuroinflammation occurring during the presymptomatic stages of NDDs. The identification of distinct homogeneous presymptomatic profiles of patients will help characterize the heterogeneity of the presymptomatic phase and enable the association of markers with disease onset or progression. The project also aims to identify critical periods of modification of different markers during the presymptomatic stage and to estimate optimal time windows of early intervention for each disease.

This ambitious, cross-disciplinary project, with no international equivalent, is only possible in the exceptional environment of the Pitié-Salpêtrière hospital, which brings together expert centers for neurodegenerative diseases, national reference centers for rare diseases, research teams and technical platforms of Paris Brain Institute. The program will open new venues to understand the molecular mechanisms involved in the genesis of these diseases.

The project's goals

The project's goals

Aim1: Create a unique resource to investigate the pre-symptomatic phase of neur-degenerative / -inflammatory diseases. 

The collection of clinical (neurological, neuropsychological and cognitive assessments), imaging and neurophysiology (anatomical, sensorimotor and behavior markers, explorations with MEG, EEG, MRI imaging), molecular biomarkers (identified in blood and samples, and through transcriptomic, proteomic and metabolomics) is required of the in-depth investigation of early stages of diseases.


Aim 2: Derive biomarkers to define disease endotypes and comorbidities and predict disease conversion and progression. 

The association of biomarkers with disease spectrum, conversion and progression will be crucial. 
 

News that might interest you

Le cortex moteur
Origin of Lance-Adams Syndrome Finally Elucidated
First described 60 years ago, chronic myoclonus following cerebral anoxia is now known as Lance-Adams syndrome. This is a severe disorder whose mechanisms were, until now, poorly understood. Geoffroy Vellieux, Vincent Navarro, and their colleagues at...
06.16.2025 Research, science & health
Tiré de New Theory of Colours de Mary Gartside, 1808
Aphantasia Might Be Linked to Alterations in Brain Connectivity
Thanks to 7T fMRI, researchers from Paris Brain Institute and NeuroSpin, the CEA's neuroimaging centre, are exploring the neural substrate of visual imagery at very high resolution for the first time. Their results, publiés [i] in Cortex, pave the...
06.06.2025 Research, science & health
Le développement du cerveau a une part d’aléatoire
The stochastic aspect of brain development
Although every person’s personality is the result of genetic and environmental factors, these are not the only factors at play. Bassem Hassan and his team at Paris Brain Institute have discovered that, in fruit flies (drosophila), individuality also...
05.12.2025 Research, science & health
Analyse MERSCOPE
New treatment pathways for brain malformation-linked focal epilepsy?
A study by Stéphanie Baulac’s team has revealed somatic mutations in different cell types in patients with type 2 focal cortical dysplasia. This disease causes drug-resistant epileptic seizures, for which the main treatment option is currently...
05.12.2025 Research, science & health
Un iceberg
The ICEBERG cohort, 10 years of collective scientific and medical mobilization
The ICEBERG cohort, initiated 10 years ago, is interested in studying factors predictive of the onset and progression of Parkinson’s disease.
05.15.2025 Research, science & health
La huntingtine est une protéine indispensable au développement embryonnaire, à la formation et au maintien du tissu cérébral.
Huntington's Disease: The Energy Hypothesis Gets Traction
Huntington's disease, a rare hereditary neurological disorder, is associated with an energy deficit that precedes the onset of symptoms and is closely linked to their progression. At Paris Brain Institute, Fanny Mochel and her colleagues are testing...
02.11.2025 Research, science & health
See all our news